CG · NASDAQ
The Carlyle Group Inc.
$39.06 -0.01 (-0.03%)
Company overview
The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it focuses on management-led leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, and venture and growth capital financings. The firm operates across four segments: Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. It typically invests in healthcare, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, technology, real estate, financial services, telecommunications, media, and logistics sectors. Within healthcare, it invests in healthcare services, outsourcing services, clinical trial companies, managed care, pharmaceuticals, pharmaceutical-related services, healthcare IT, medical products, and devices.
- Sector
- Financial Services
- Industry
- Asset Management
- Exchange
- NASDAQ
- Market cap
- $13.9B
- Employees
- 2,300
- Headquarters
- Washington, DC
- Website
- carlyle.com
- CEO
- Harvey Mitchell Schwartz
- Listed
- May 3, 2012
- P/E
- 25.66
- Dividend yield
- 2.88%
Company financials
- Revenue
- $4B
- Gross profit
- $2.9B
- Operating income
- $886M
- EBITDA
- $1B
- Net income
- $547M
- EPS
- $1.52
- Total assets
- $29.8B
- Total debt
- $14.6B
- Gross margin
- 73.08%
- Net margin
- 13.70%
- Earnings yield
- 3.90%
Showing FY 2025
CG
1D
NASDAQ
O38.50H39.10L38.27C39.07+0.54 (+1.40%)Vol525.73K